Dengue is the world's most prevalent and important arboviral disease. More than 50% of the
world's population lives at daily risk of infection and it is estimated more than 95 million …

Dengue is a vectorborne infectious disease caused by dengue viruses (DENVs), which are
predominantly transmitted by Aedes aegypti and Aedes albopictus mosquitos. Dengue is …

Dengue has become a major global public health threat with almost half of the world's
population living in at-risk areas. Vaccination would likely represent an effective strategy for …

The w Mel strain of Wolbachia can reduce the permissiveness of Aedes aegypti mosquitoes
to disseminated arboviral infections. Here, we report that w Mel-infected Ae. aegypti (Ho Chi …

More than half of the world's population lives in areas at risk for dengue virus infection. A
vaccine will be pivotal to controlling spread, however, the only licensed vaccine, Dengvaxia …

ABSTRACT A tetravalent live-attenuated 3-dose vaccine composed of chimeras of yellow
fever 17D and the four dengue viruses (CYD, also called Dengvaxia) completed phase 3 …

Dengue Virus (DENV) is an arbovirus (arthropod-borne virus). Four serotypes of DENV are
responsible for the infectious disease called dengue that annually affects nearly 400 million …

Objectives Dengue infection is spreading worldwide. The clinical spectrum is broad and
includes asymptomatic infections. This review provides an overview of the different …

Introduction: Dengue is an important and still growing public health problem associated with
substantial morbidity, as well as significant social and economic impact. The present review …

Following publication of results from two phase-3 clinical trials in 10 countries or territories,
endemic countries began licensing the first dengue vaccine in 2015. Using a published …